Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04336514
Other study ID # 18-5921
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 6, 2020
Est. completion date August 30, 2021

Study information

Verified date April 2021
Source University Health Network, Toronto
Contact Ann Russell, PhD
Phone 416-596-3101
Email arussell@michener.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Musculoskeletal deformities of the foot and abnormal biomechanics can create areas of high pressure over bony prominences on the plantar aspect of the foot and often lead to the formation of calluses and corns. Calluses and corns are reported to be the most prevalent foot conditions affecting peoples' lifestyles due to pain and disability. Redistribution of plantar pressure away from areas of high pressure offloading using felt pads to treat corns and calluses is a common practice in chiropody. A more comprehensive understanding of how rapidly the felt pads compress and become less effective in offloading pressure is needed to design better treatment plans to manage calluses and corns and improve patients' quality of life. The objectives of this study are: 1) develop a guideline which informs, at what duration (number of weeks) the semi compressed felt (SCF) Plantar Metatarsal Pad (PMP) should be replaced to manage plantar forefoot callus; 2) Test the guideline by replacing the SCF padding at the determined time interval. The study will be conducted at the Michener Chiropody Clinic at the Michener Institute of Education at UHN. In order to address patient selection bias, the investigators will be recruiting the first 25-40 participants presenting with forefoot callus who meet the inclusion criteria and consent to participate in the study. An exploratory, descriptive and analytic repeated measures study design will be used to address our research questions. The descriptive approach will provide insight into the nature of change over time in the dependent variables, pain and pressure, and an analytic approach will enable further insight into the relationship between those variables. The quantitative metrics used are average plantar pressure at the callus site, as well as self-reported pain using a Visual-Analog Scale (VAS). Results from the first phase will inform the development of the guideline for pad replacement, which in turn will be tested in the next phase of the study.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date August 30, 2021
Est. primary completion date May 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: The participants to be studied are from the general population with callus on the plantar aspect of the forefoot. The participants must have appropriate footwear with adequate space for pads and must be agreeable to wearing them majority of the study period for weight bearing activities. Participants must be willing to attend clinic every two weeks for 8 weeks Exclusion Criteria: Participants with an active or past history of foot ulcers, those with Charcot neuroarthropathy as well as those who were unable to walk unaided will be excluded from the study. All participants will undergo a neuropathic assessment, including the vibration using a 127Hz tuning fork, protective sensation using a 10 gram monofilament and proprioception to exclude patients with neuropathy. Participants will be excluded if they have any foot skin disorders such as infections, dermatitis and psoriasis. Furthermore, anyone with neuropathy or diabetes for over 5 years will be excluded from the study.

Study Design


Intervention

Device:
Semi-compressed felt pad (SCF)
Participants with forefoot callus will receive routine treatment of debridement of callus. Along with the debridement, a Plantar Metatarsal Pad (PMP) made of Semi-Compressed Felt (SCF) with appropriate cut outs will be placed in their shoes. The thickness of the SCF would be selected based on the patient weight, and appropriateness of the thickness would be confirmed by the Medilogic pressure measurement. A 50% pressure reduction is the desired outcome.

Locations

Country Name City State
Canada Michener Chiropody Clinic Toronto Ontario

Sponsors (2)

Lead Sponsor Collaborator
University Health Network, Toronto The Michener Institute for Education at UHN

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Average Plantar Pressure 0-8 weeks The change in the average value of plantar pressure identified during the gait cycle from baseline to 8 weeks after the application of the semi-compressed felt pad. Change from baseline to 8 weeks
Secondary Perceived pain Self-reported levels of pain will be recorded using the Visual Analogue Scale (0-100) 0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Physical Activity 23 item questionnaire assessing the daily activity profiles of the participants. 0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Sociodemographic data- employment Location of place of employment - at home or outside of home 0 (pre and post insertion of SCF), 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Sociodemographic data - job description Brief description of job demands 0 weeks
Secondary Daily physical activity- workday sitting time Time spent sitting on a typical work day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- weekend sitting time Time spent sitting on a typical weekend day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- work day standing time Time spent standing on a typical work day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- weekend standing time Time spent standing on a typical weekend day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- workday walking time Time spent walking or running or climbing on a typical work day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- weekend walking time Time spent walking or running or climbing on a typical weekend day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- workday time spent on feet Category of time spent on feet in hours on a typical work day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- weekend time spent on feet Category of time spent on feet in hours on a typical weekend day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- workday strain on feet Category of foot strain experienced on a typical work day 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- weekend strain on feet Category of foot strain experienced on a typical weekend day 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- time of wearing pad on a workday Category of time for which pad was worn on a typical work day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
Secondary Daily physical activity- time of wearing pad on a weekend day Category of time for which pad was worn on a typical weekend day in hours 0 weeks, 2 weeks, 4 weeks, 6 weeks, and 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT00239135 - Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel Phase 2
Recruiting NCT06206681 - Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Completed NCT00115154 - Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands Phase 4
Completed NCT00116649 - Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis Phase 4
Recruiting NCT05942794 - Identification of Oral Lesions Through an Autofluorescence System N/A
Withdrawn NCT02851693 - Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection N/A
Withdrawn NCT02813902 - A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors Phase 1
Completed NCT00121511 - The Effect of Efudex Treatment on Photoaged Skin N/A
Completed NCT00114023 - 1-Year Follow up to the 1473-IMIQ Study Phase 3
Completed NCT05060237 - Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp Phase 1
Recruiting NCT02737176 - Tobacco Cessation Intervention Study for Oral Diseases N/A
Completed NCT00110682 - Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses Phase 4